BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8976800)

  • 1. Is there a therapeutic future for "potassium channel openers'?
    Lawson K
    Clin Sci (Lond); 1996 Dec; 91(6):651-63. PubMed ID: 8976800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium channel openers as potential therapeutic weapons in ion channel disease.
    Lawson K
    Kidney Int; 2000 Mar; 57(3):838-45. PubMed ID: 10720937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potassium channel activation: a potential therapeutic approach?
    Lawson K
    Pharmacol Ther; 1996; 70(1):39-63. PubMed ID: 8804110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potassium channel openers act through an activation of ATP-sensitive K+ channels in guinea-pig cardiac myocytes.
    Escande D; Thuringer D; Le Guern S; Courteix J; Laville M; Cavero I
    Pflugers Arch; 1989 Sep; 414(6):669-75. PubMed ID: 2510125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-sensitive potassium channels in smooth muscle cells from guinea pig urinary bladder.
    Bonev AD; Nelson MT
    Am J Physiol; 1993 May; 264(5 Pt 1):C1190-200. PubMed ID: 8498480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do potassium channel openers compete with ATP to activate ATP sensitive potassium channels?
    Henry P; Escande D
    Cardiovasc Res; 1994 Jun; 28(6):754-9. PubMed ID: 7923275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
    Quasthoff S; Franke C; Hatt H; Richter-Turtur M
    Neurosci Lett; 1990 Nov; 119(2):191-4. PubMed ID: 2126363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
    Atwal KS; Grover GJ; Ahmed SZ; Ferrara FN; Harper TW; Kim KS; Sleph PG; Dzwonczyk S; Russell AD; Moreland S
    J Med Chem; 1993 Nov; 36(24):3971-4. PubMed ID: 8254626
    [No Abstract]   [Full Text] [Related]  

  • 10. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mitochondrial KATP channel as a receptor for potassium channel openers.
    Garlid KD; Paucek P; Yarov-Yarovoy V; Sun X; Schindler PA
    J Biol Chem; 1996 Apr; 271(15):8796-9. PubMed ID: 8621517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of potassium channel openers.
    Andersson KE
    Pharmacol Toxicol; 1992 Apr; 70(4):244-54. PubMed ID: 1535127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
    Satoh K
    Nihon Rinsho; 1993 May; 51(5):1293-8. PubMed ID: 8331797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and pharmacological evaluation of R/S-3,4-dihydro-2,2-dimethyl- 6-halo-4-(phenylaminocarbonylamino)-2H-1-benzopyrans: toward tissue-selective pancreatic beta-cell KATP channel openers structurally related to (+/-)-cromakalim.
    Sebille S; Gall D; de Tullio P; Florence X; Lebrun P; Pirotte B
    J Med Chem; 2006 Jul; 49(15):4690-7. PubMed ID: 16854075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of ATP-sensitive K+ channel activity and contractile behavior in mammalian ventricle by the potassium channel openers cromakalim and RP49356.
    Ripoll C; Lederer WJ; Nichols CG
    J Pharmacol Exp Ther; 1990 Nov; 255(2):429-35. PubMed ID: 2243335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smooth muscle K+ channel openers; their pharmacology and clinical potential.
    Weston AH
    Pflugers Arch; 1989; 414 Suppl 1():S99-105. PubMed ID: 2674897
    [No Abstract]   [Full Text] [Related]  

  • 17. Recent developments in the chemistry of potassium channel activators: the cromakalim analogs.
    Sebille S; De Tullio P; Boverie S; Antoine MH; Lebrun P; Pirotte B
    Curr Med Chem; 2004 May; 11(9):1213-22. PubMed ID: 15134515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
    Grover GJ
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S18-27. PubMed ID: 7898104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
    Sellers AJ; Boden PR; Ashford ML
    Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ATP-sensitive K+ channel openers on pacemaker activity in isolated single rabbit sino-atrial node cells.
    Satoh H
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):863-8. PubMed ID: 7509906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.